Diagnosis and Characterization of Dengue Fever in Children

NCT00946218 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 258

Last updated 2011-10-05

No results posted yet for this study

Summary

Dengue virus is an arbovirus transmitted by mosquitoes which causes significant morbidity and mortality among children in tropical regions, especially in resource limited countries. The objective of this protocol is to compare the sensitivity and specificity of clinical gestalt and two rapid antigen tests for dengue virus and to compare the gene expression of leukocytes in distinct dengue fever disease phenotypes module-based RNA microarray technology.

Conditions

  • Dengue Fever

Sponsors & Collaborators

Principal Investigators

  • Elisabeth Adderson, MD · St. Jude Children's Research Hospital

Eligibility

Min Age
6 Months
Max Age
11 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • United States
  • El Salvador

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00946218 on ClinicalTrials.gov